Windlas Biotech per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹31.63₹31.59₹29.03₹27.95₹19.71
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹31.25₹31.14₹28.71₹27.86₹19.71
₹275.20₹275.20₹241.31₹216.51₹192.42
₹446.37₹428.36₹362.54₹303.37₹245.19
—₹49.71₹32.55₹52.37₹29.14
₹17.66₹17.66₹7.65₹34.25−₹4.73
—₹5.76₹5.48₹3.99₹3.65
2.12.12.12.12.1
Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

WINDLAS₹888.70

Windlas Biotech Limited

· Pharma & Health
₹ CrorePeersHESTERBIOINDOCOSAIPARENTSYNCOMFPANACEABIONGLFINEHIKALJAGSNPHARMMcap ₹1,876 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS19.7127.9529.0331.5931.63
Diluted EPS19.7127.8628.7131.1431.25
Book Value per Share192.42216.51241.31275.20275.20
Revenue per Share245.19303.37362.54428.36446.37
Cash Flow per Share29.1452.3732.5549.71—
Free Cash Flow per Share-4.7334.257.6517.6617.66
Dividends per Share3.653.995.485.76—
Shares Outstanding (cr)2.12.12.12.12.1
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.